: Interplay between innate and adaptive immune response is currently emerging as a novel topic in immunology with a potential impact in medical sciences. Among many different molecules participating in these processes is the family of antigen-presenting class IMHC, which orchestrate NK cell and T cell responses and regulate their interactions. The focus of this proposal is the nonclassical (class Ib) MHC, Qa-2, similar to class la and to human class Ib, HLA-G. Multiple genes and multiple alternatively spliced transcripts with potentially different capabilities or regulating immunity encode Qa-2. Our laboratory played a major role in defining the peptide-binding properties, the crystal structure and the role in NK cell inhibition by GPl-linked, canonical Qa-2. We now plan to use our past expertise and reagents to (1) identify novel isoforms of Qa-2 and determine their expression patterns;(2) evaluate their interactions with components of the innate immune system (NK cells); and (3) study their function in inducing protective adaptive immune response during tumor rejection. The specific hypotheses to be addressed include the notion that peptide-loaded Qa-2 engage NK and T cell receptors and the speculation that they play a specialized role in elimination of stressed/malignantly-transformed cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019624-25
Application #
7035766
Study Section
Immunobiology Study Section (IMB)
Program Officer
Macchiarini, Francesca
Project Start
1992-06-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
25
Fiscal Year
2006
Total Cost
$342,752
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Renthal, Nora E; Guidry, Paula A; Shanmuganad, Sharmila et al. (2011) Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide. Immunogenetics 63:57-64
Swanson 2nd, Phillip A; Pack, Christopher D; Hadley, Annette et al. (2008) An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med 205:1647-57
Chiang, Eugene Y; Stroynowski, Iwona (2006) The role of structurally conserved class I MHC in tumor rejection: contribution of the Q8 locus. J Immunol 177:2123-30
Chen, Ming; Tabaczewski, Piotr; Truscott, Steven M et al. (2005) Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. J Immunol 175:1047-55
Chiang, Eugene Y; Stroynowski, Iwona (2005) Protective immunity against disparate tumors is mediated by a nonpolymorphic MHC class I molecule. J Immunol 174:5367-74
Chiang, Eugene Y; Stroynowski, Iwona (2004) A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor. J Immunol 173:4394-401
Chiang, Eugene Y; Henson, Maile; Stroynowski, Iwona (2003) Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth. J Immunol 170:4515-23
Gao, Jian-Xin; Liu, Xingluo; Wen, Jing et al. (2003) Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells. Blood 102:4456-63
Chiang, Eugene Y; Henson, Maile; Stroynowski, Iwona (2002) The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. J Immunol 168:2200-11
Ungchusri, T; Chiang, E Y; Brown, G et al. (2001) Widespread expression of the nonclassical class I Qa-2 antigens in hemopoietic and nonhemopoietic cells. Immunogenetics 53:455-67

Showing the most recent 10 out of 33 publications